x

¿Aún no está registrado?

Cree su cuenta. Regístrese en Elsevier y obtendrá: información relevante, máxima actualización y promociones exclusivas.

Registrarme ahora
Help - - Sign up - Phone number 902 888 740
Search

Indexed in:

Index Medicus/Medline, Latindex, IBECS, IME, SCOPUS y MEDES

Metrics

  • SCImago Journal Rank (SJR):0,138
  • Source Normalized Impact per Paper (SNIP):0,141
Semergen 2000;26:145-52 - DOI: 10.1016/S1138-3593(00)73558-1
La menopausia en la medicina general/de familia
Felipe Chavida
Equipo de Atención Primaria de Brihuega. Guadalajara
This article is only available in PDF
Biblografía
1.
G.A. Greendale,N.P. Lee,E.R. Arriola
The menopause
2.
N.F. Woods,E.S. Mitchell
Anticipating menopause: observations from the Seattle Midlife Women's Health Study
Menopause, 6 (1999), pp. 167-173
3.
O.L. Svendsen,C. Hassager,C. Christiansen
Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women
Am J Med, 95 (1993), pp. 121-140
4.
M.S. LeBoff,L. Kohlmeier,S. Hurwitz,J. Franklin,J. Wright,J. Howacki
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture
JAMA, 281 (1999), pp. 1505-1511
5.
S. McNagny
Prescribing hormone replacement therapy for menopausal women
Ann Intern Med, 131 (1999), pp. 605-616
6.
E. Barrett-Connor
Hormone replacement therapy
BMJ, 317 (1998), pp. 457-461
7.
Novak's gynecology (12.a ed.),
8.
Clinical gynecologic endocrinology and infertility (5.a ed.),
9.
L. Weinstein,C. Bewtra,J.C. Gallagher
Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient
Am J Obstet Gynecol, 162 (1990), pp. 1534-1539
10.
T.K. Chung,S.K. Yip,P. Lam,A.M. Chang,C.J. Haines
A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms
Maturitas, 25 (1996), pp. 115-123
11.
C.A. Staropoli,J.A. Flaws,T.I. Bush,A.W. Moulton
Predictors of menopausal hot flashes
J Womens Healthy, 7 (1998), pp. 1149-1155
12.
C. Egarter,M. Sator,P. Berghammer,J. Huber
Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women
Int J Gynaecol Obstet, 64 (1999), pp. 281-286
13.
K. Yaffe,G. Sawaya,I. Lieberburg,D. Grady
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia
JAMA, 279 (1998), pp. 688-695
14.
S. Waring,W.A. Rocca,R.C. Petersen,P.C. O'Brian,E.G. Tangalos,E. Kokmen
Postmenopausal estrogen replacement therapy and risk of Alzheimer disease: a population-based study
Neurology, 52 (1999), pp. 965-970
15.
E.E. Calle
Hormone replacement therapy and colorectal cancer: interpreting the evidence
Cancer Causes Control, 8 (1997), pp. 127-129
16.
The Eye-Disease Case-Control Study Group
Risk factors for neovascular age-related macular degeneration
Arch Ophthalmol, 110 (1992), pp. 1705-1708
17.
T.B. Pearlstein
Hormones and depression: what age the facts about premenstrual syndrome, menopause, and hormone replacement therapy?
Am J Obstet Gynecol, 173 (1995), pp. 646-653
18.
B.L. Harlow,D.W. Cramer,K.M. Annis
Association of medically treated depression an age at natural menopause
Am J Epidemiol, 141 (1995), pp. 1170-1179
19.
N.E. Avis,D. Brambilla,S.M. McKinlay,K. Vass
A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study
Ann Epidemiol, 4 (1994), pp. 214-220
20.
P.A. Kaufert,P. Gilbert,R. Tate
The Manitoba Project: a re-examination of the link between menopause and depression
Maturitas, 14 (1992), pp. 143-155
21.
L. Nicol-Smith
Causality, menopause, and depression: a critical review of the literature
BMJ, 313 (1996), pp. 1229-1232
22.
H. Joffe,L.S. Cohen,J. Hennen,K. Carlson
The perimenopause is a period of risk for depressive symptoms in middle-aged women [NR 13]
The American Psychiatric Association 152nd Annual Meeting, Washington, DC, (1999),
23.
C. Cooper,E.J. Atkinson,W.M. O'Fallon,L.J. Melton
Incidence of clinical diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989
J Bone Min Res, 7 (1992), pp. 221-227
24.
R.P. Heaney
Bone mass, bone loss, and osteoporosis prophylaxis
Ann Intern Med, 128 (1998), pp. 313-314
25.
S.L. Hui,C.W. Slemenda,C.C. Johnston Jr.
Age and bone mass as predictors of fracture in a prospective study
J Clin Invest, 81 (1988), pp. 1804-1809 http://dx.doi.org/10.1172/JCI113523
26.
T.J. Wilkin
Changing perceptions in osteoporosis
BMJ, 318 (1999), pp. 862-864
27.
L. Sampietro-Colom,C. Almazán,A. Granados
Evaluación de la densitometría ósea
Agència d'Avaluació de Tecnologia Mèdica, mayo, (1993),
28.
D. Marshall,O. Johnell,H. Wedel
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
BMJ, 312 (1996), pp. 1254-1259
29.
Physician's Guide to prevention and treatment of osteoporosis
30.
N.F. Col,M.H. Eckman,R.H. Karas,S.G. Panker,R.J. Goldberg,E.M. Ross
Patient-specific decisions about hormone replacement therapy in postmenopausal women
JAMA, 277 (1997), pp. 1140-1147
31.
K. Grady,S.M. Rubin,D.B. Petitti,C.S. Fox,D. Black,B. Ettinger
Hormone therapy to prevent disease and prolong life in postmenopausal women
Ann Intern Med, 117 (1992), pp. 1016-1037
32.
B. Ettinger,D. Black,B. Mitlak,R.K. Knickerbocker,T. Nickelsen,H.K. Genant
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
JAMA, 282 (1999), pp. 637-645
33.
J. Studd,I. Arnala,P.M. Kicovic,D. Zamblera,H. Kroger,N. Holland
A randomized study of tibolone on bone mineral density in osteoporotic postmenopausal women with previous fractures
Obstet Gynecol, 92 (1998), pp. 574-579
34.
S.A. Beardsworth,C.E. Kearney,D.W. Purdy
Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: a two-year randomised controlled trial
Br J Obstet Gynaecol, 106 (1999), pp. 678-683
35.
S.L. Crawford,C.B. Johannes
The epidemiology of cardiovascular disease in postmenopausal women
J Clin Endocrinol Metab, 84 (1999), pp. 1803-1806
36.
G.A. Colditz,W.C. Willet,M.J. Stampfer,B. Rosner,F.E. Speizer,C.H. Hennekens
Menopause and the risk of coronary heart disease in women
N Engl J Med, 316 (1987), pp. 1105-1110 http://dx.doi.org/10.1056/NEJM198704303161801
37.
T. Bush
The epidemiology of cardiovascular disease in post menopausal women
Ann N Y Acad Sci, 592 (1990), pp. 263-271
38.
H. Tunstall-Pedoe
Myth and paradox of coronary risk and the menopause
39.
L. Tomás Abadal
Riesgo cardiovascular en la menopausia: mito, paradoja o realidad. Importancia de las observaciones clínicas frente a la interpretación de los datos estadísticos
Rev Esp Cardiol, 52 (1999), pp. 463-466
40.
G.M. Rosano,G. Panina
Oestrogens and the heart
Therapie, 54 (1999), pp. 381-385
41.
G.M. Rosano,G. Panina
Cardiovascular pharmacology of hormone replacement therapy
Drugs Aging, 15 (1999), pp. 219-234
42.
The Writing Group for the PEPI Trial
Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
JAMA, 273 (1995), pp. 199-208
43.
W.M. Van Baal,R.G. Smoleders,M.J. Van der Mooren,T. Teerlink,P. Kenemans
Hormone replacement therapy and plasma homocysteine levels
Obstet Gynecol, 94 (1999), pp. 485-491
44.
A. Tchernof,J. Calles-Escandon,C. Sites,E.T. Poehlman
Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy
Coron Arter Disk, 9 (1998), pp. 503-511
45.
S.R. Lindheim,D.M. Duffy,T. Kijima,M.A. Vijod,F.Z. Stanazyk,R.A. Lobo
The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women
Fertil Steril, 62 (1994), pp. 1176-1180
46.
T. Raudaskoski,C. Tomas,T. Laatikainen
Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel
Acta Obstet Gynecol Scand, 78 (1999), pp. 540-545
47.
A.C. Duncan,H. Lyall,R.N. Roberts,J.R. Petrie,M.J. Perera,S. Monaghan
The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women
J Clin Endocrinol Metabol, 84 (1999), pp. 2402-2409
48.
C. Castelo-Branco,E.F. Casals,F. Figueras,A. Sanjuán,J.J. Vicente
Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AL and B
Menopause, 6 (1999), pp. 92-97
49.
K. Rödstrom,C. Bengtsson,L. Lissner,C. Björkelund
Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden
BMJ, 319 (1999), pp. 890-893
50.
S. Hulley,D. Grady,T. Bush,C. Furberg,D. Herrington,B. Riggs
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group
JAMA, 280 (1998), pp. 605-613
51.
Collaborative Group on Hormonal Factors in Breast Cancer
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
Lancet, 350 (1997), pp. 1047-1059
52.
K.K. Steinberg,S.B. Thacker,S.J. Smith,D.F. Stroup,M.M. Zack,W.D. Flanders
A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer
JAMA, 265 (1991), pp. 1985-1990
53.
Europe Menopause Society
European consensus development conference on menopause
Hum Reprod, 11 (1996), pp. 975-979
54.
S.M. Gapstur,M. Morrow,T.A. Sellers
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study
JAMA, 281 (1999), pp. 2091-2097
55.
S. Stallard,J.C. Litherland,C.M. Cordiner,H.M. Dobson,W.D. George,E.A. Mallon
Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study
BMJ, 320 (2000), pp. 348-349
56.
C. Schairer,J. Lubin,R. Troisi,M.H. Sturgeon,L. Brinton,R. Hoover
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
JAMA, 283 (2000),
57.
N.E. Col,S.G. Pauker,R. Goldberg,M.H. Eckman,E.M. Ross,J.B. Wong
Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women
Arch Intern Med, 159 (1999), pp. 1458-1466

( ! ) Notice: Undefined index: email in /var/www/html/includes_ws/librerias/html/item.php on line 1232
Call Stack
#TimeMemoryFunctionLocation
10.0004255320{main}( ).../index.php:0
20.499333100104include( '/var/www/html/elsevier/plantilla/plantilla-sidebars.php' ).../index.php:101
30.504433109296include( '/var/www/html/elsevier/plantilla/cuerpo.php' ).../plantilla-sidebars.php:15
40.543033123664include( '/var/www/html/elsevier/plantilla/cuerpo/central.php' ).../cuerpo.php:11
50.543533173376include( '/var/www/html/elsevier/contenidos/revista/item.php' ).../central.php:3
60.664033266144getAutorCorrespondenciaHTML( ).../item.php:320

( ! ) Notice: Undefined index: email in /var/www/html/includes_ws/librerias/html/item.php on line 1232
Call Stack
#TimeMemoryFunctionLocation
10.0004255320{main}( ).../index.php:0
20.499333100104include( '/var/www/html/elsevier/plantilla/plantilla-sidebars.php' ).../index.php:101
30.504433109296include( '/var/www/html/elsevier/plantilla/cuerpo.php' ).../plantilla-sidebars.php:15
40.543033123664include( '/var/www/html/elsevier/plantilla/cuerpo/central.php' ).../cuerpo.php:11
50.543533173376include( '/var/www/html/elsevier/contenidos/revista/item.php' ).../central.php:3
60.664033266144getAutorCorrespondenciaHTML( ).../item.php:320
Correspondencia: Dr. F. Chavida. Centro de Salud de Brihuega. Plaza del Jardinillo, 1. 19400 Brihuega. Guadalajara (Felipe Chavida )
Copyright © 2000. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)